PT100949A - Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos - Google Patents

Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos

Info

Publication number
PT100949A
PT100949A PT100949A PT10094992A PT100949A PT 100949 A PT100949 A PT 100949A PT 100949 A PT100949 A PT 100949A PT 10094992 A PT10094992 A PT 10094992A PT 100949 A PT100949 A PT 100949A
Authority
PT
Portugal
Prior art keywords
medications
tri
preparation
pharmaceutical compositions
use procedure
Prior art date
Application number
PT100949A
Other languages
English (en)
Inventor
Kenneth John Murray
Roderick Alan Porter
Hunter Douglas Prain
Brian Herbert Warrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT100949A publication Critical patent/PT100949A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT100949A 1991-10-11 1992-10-09 Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos PT100949A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919121651A GB9121651D0 (en) 1991-10-11 1991-10-11 Chemical compounds

Publications (1)

Publication Number Publication Date
PT100949A true PT100949A (pt) 1994-06-30

Family

ID=10702801

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100949A PT100949A (pt) 1991-10-11 1992-10-09 Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos

Country Status (9)

Country Link
EP (1) EP0607217A1 (pt)
JP (1) JPH07500102A (pt)
AU (1) AU654051B2 (pt)
CA (1) CA2120756A1 (pt)
GB (1) GB9121651D0 (pt)
MX (1) MX9205851A (pt)
PT (1) PT100949A (pt)
WO (1) WO1993007137A1 (pt)
ZA (1) ZA927786B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4323916A1 (de) * 1993-07-16 1995-01-19 Basf Ag Substituierte 2-Phenylpyridine
DE102004050196A1 (de) * 2004-10-15 2006-04-20 Sanofi-Aventis Deutschland Gmbh Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
CN101602687A (zh) * 2008-06-13 2009-12-16 上海特化医药科技有限公司 6-硝基苯乙酮类化合物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809481D0 (en) * 1988-04-21 1988-05-25 Smith Kline French Lab Chemical compounds
GB8923131D0 (en) * 1989-10-13 1989-11-29 Smith Kline French Lab Chemical compounds
NZ238202A (en) * 1990-05-21 1994-01-26 Smith Kline French Lab Pyridine and benzene derivatives and medicaments.

Also Published As

Publication number Publication date
CA2120756A1 (en) 1993-04-15
JPH07500102A (ja) 1995-01-05
ZA927786B (en) 1994-04-11
EP0607217A1 (en) 1994-07-27
AU654051B2 (en) 1994-10-20
GB9121651D0 (en) 1991-11-27
MX9205851A (es) 1993-06-01
AU2693392A (en) 1993-05-03
WO1993007137A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
FI943571A (fi) 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
IT8847556A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
FI942913A (fi) Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
IT8848714A0 (it) Derivati di adenosina, composizioni farmaceutiche che li contengono erelativo procedimento di preparazione ed appplicazione
IT1200092B (it) Derivati amminopropossi, loro preparazione e loro impiego come medicamenti
FI951789A (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
IT1203743B (it) Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti
ITMI912237A0 (it) Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono
IT1219542B (it) Derivati pepticidi,loro preparazione e loro impiego come medicamenti
IT1237474B (it) Composti tripeptidici e loro uso farmaceutico come immuno-modulatori
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
IT1227436B (it) Derivati di 1-azabicicloalcani, loro procedimento di preparazione e loro applicazione come farmaci
FI955679A0 (fi) Piperidiinijohdannaisia, niiden valmistus ja käyttö
FI945439A (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
FI961977A (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
PT100949A (pt) Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos
DE3782378D1 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
FR2636063B1 (fr) Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application
IT8948610A0 (it) Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono
IT9021305A0 (it) Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono
IL104347A0 (en) Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
BR9405818A (pt) Derivados de ácido pirazolil-acrilico produtos intermediános e seu uso como microbicidas
ITMI910846A1 (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
NO921908D0 (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter
IT8548195A0 (it) Derivati della naftossazina, loro preparazione, loro applicazione come medicamenti e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19931122

FC3A Refusal

Effective date: 19990503